Navigation Links
Indevus Announces Submission of New Drug Application
Date:8/28/2007

y the analysis of the safety measurements collected and the persistence with study treatment. Further, the spectrum of adverse events reported were comparable to other injectable hypogonadism treatments reported in the literature. There were no significant adverse changes in laboratory parameters with NEBIDO treatment.

About NEBIDO

NEBIDO(R) is a long-acting depot preparation of testosterone undecanoate, developed for the treatment of male hypogonadism. NEBIDO is expected to be the first three-month testosterone preparation available in the U.S. in the growing market for testosterone therapies. Indevus acquired U.S. rights to NEBIDO from Bayer Schering Pharma AG, Germany in July 2005.

About Hypogonadism

Male hypogonadism is an increasingly recognized medical condition characterized by a reduced or absent secretion of testosterone from the testes. Reduced testosterone levels can lead to health problems and significantly impair quality of life. Common effects of hypogonadism include decreased sexual desire, muscle loss and weakness, as well as an increased risk of osteoporosis. Today, there are an estimated four to five million men in the U.S. who suffer from hypogonadism. Of this group, less than ten percent are currently receiving treatment with testosterone therapy.

About Indevus

Indevus Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the acquisition, development and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA(R) XR and SANCTURA(R) for overactive bladder, VANTAS(R) for advanced prostate cancer, SUPPRELIN(R) LA, for central precocious puberty, and DELATESTRYL(R) to treat male hypogonadism. The Indevus development pipeline contains multiple compounds within the Company's core therapeutic areas in addition to several partnered or partnerable programs. The most advanced compounds in development include, VALSTAR(R) for bladder c
'/>"/>

SOURCE Indevus Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Indevus Announces Presentation of Pagoclone Data at 47th Annual New Clinical Drug Evaluation Unit Meeting
2. Indevus Reports Positive Data From Phase III NEBIDO Trial
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 3SBio Inc. (NASDAQ: SSRX ... China -based biotechnology company focused on ... today that, at an extraordinary general meeting held ... favor of the proposal to authorize and approve ... dated February 8, 2013, among Decade Sunshine Limited, ...
(Date:5/23/2013)... Corporation (NYSE: HAE ) announced today that ... present at The Deutsche Bank 38 th Annual dbAccess ... on May 29, 2013 at 1:30pm Eastern time.  ... may access Mr. Lindop,s presentation live via webcast at: ... (NYSE: HAE ) is a global healthcare company ...
(Date:5/23/2013)... , May 23, 2013  TeamHealth Medical ... nurse triage and nurse advice lines, announces its ... comprising physician, nursing and administrative leaders, provides clinical ... quality and cost-effective services for hospital clients, physician ... national healthcare system evolves, it,s imperative to continuously ...
Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3TeamHealth Medical Call Center Forms Clinical Advisory Committee 2
... N.M., Jan. 26, 2011 New Mexico Software, ... a developer of medical IT services and solutions that ... announced today the implementation of a software module that ... XR-EXpress telemedicine services to other systems. CEO ...
... Solta Medical, Inc. (Nasdaq: SLTM ), a ... it will release its financial results for the full year ... on Tuesday, February 22, 2011.  The Company will also host ... at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss ...
Cached Medicine Technology:New Mexico Software Unveils Additional Software Significantly Expanding Availability of Its Telemedicine Services 2New Mexico Software Unveils Additional Software Significantly Expanding Availability of Its Telemedicine Services 3Solta Medical Announces Full Year and Fourth Quarter 2010 Results Release and Conference Call 2
(Date:5/25/2013)... According to an article in the June ... nearly 30 million Americans tan indoors each year and an ... knowing the health risks. New research suggests that UV ... on the brains of some tanners (Go to goo.gl/hdwnz). ... I can’t say that I fully support this contention from ...
(Date:5/25/2013)... Dr. Leslie Gerstman announced today ... lift skin on the neck, on the brow and under ... Aesthetics. , Ultherapy is a non-surgical procedure for the face ... to lift the skin over time. The use of FDA-cleared ... and then treat the deepest support layers of the skin ...
(Date:5/25/2013)... 2013 A disorder of the nerves, ... neuropathy. According to neuropathy expert doctor Helen C Lin, ... that the disorder affects almost 50% of all Diabetic ... Diabetes. The high blood sugar levels in the body ... from it usually tend to have abnormally high blood ...
(Date:5/25/2013)... The report “Global Food Encapsulation Market (2012 – ... Materials, Packaging, & Geography: Trends & Forecasts” defines ... analysis and forecasting of the global revenue for ... restraining factors for the global food encapsulation markets ... market is segmented and revenue are forecasted on ...
(Date:5/25/2013)... 25, 2013 Absolute Surgical Specialists, serving Sun ... the NALA’s businesses throughout the country participating in Shop Local ... in the nationwide event as he understands what military families ... the Army. He said, “I wanted to give something back, ... but I live here too.” , Shop Local for a ...
Breaking Medicine News(10 mins):Health News:Sun Damage – Are UV Rays Addictive? 2Health News:Dr. Leslie Gerstman Is Now Offering the Non-surgical Facelifting Procedure – Ultherapy – in NYC and NJ 2Health News:Diabetic Neuropathy treatment hits new grounds- Neuracel launches the complete natural treatment 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 3Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2
... ... HIV STOPS WITH US",is the message of ... across,the country including: Boston, Long Beach and Alameda ... positive people, and a,wide spectrum of HIV negative ... providers and partners talking about real issues., ...
... using widely available and inexpensive ultrasound imaging could help ... or other adverse cardiovascular events, according to a study ... Radiology . , Researchers performed ultrasound imaging on the ... at high risk for cardiovascular disease. Of those, ultrasound ...
... reduces bleeding problems, study finds , , MONDAY, Aug. 18 (HealthDay ... wrist rather than the groin reduces the incidence of bleeding ... using the radial artery in the wrist, is not widely ... almost 600,000 catheterizations in a national database, said a report ...
... Arizona hospitals can access the new AzHHA pharmacy benefit ... immediately see improvements to their bottom ... created and is,supported by the leading pharmacy benefit consulting ... rebate,reimbursements, implementation credits and many other options not typically,available ...
... 18 Today a representative of the,Executive Board ... Local,6434 ("ULTCW") filed a letter of complaint with ... the letter written to President Stern and the ... Vice President of ULTCW and,member of its Executive ...
... Aug. 18 Actavis Group, the,international generic ... approval from the U.S. Food & Drug ... 300mg. Distribution,of the product will commence immediately., ... in,300mg strength, are the generic equivalent of ...
Cached Medicine News:Health News:New HIV Prevention/Anti-Stigma Campaign Featuring HIV Positive & Negative Persons 'TOGETHER' Launches Across the Nation 2Health News:Ultrasound used to predict heart attack risk 2Health News:Reaching the Heart Through the Wrist 2Health News:Reaching the Heart Through the Wrist 3Health News:Arizona Hospital and Healthcare Association Teams Up with ARMSRx to Bring Cost Savings to Hospitals 2Health News:Actavis Receives Approval of Generic Wellbutrin XL(R) 300mg in the U.S. 2
Hubbed drains are made of translucent silicone and include a full-length X-ray opaque stripe....
Siliconized PVC drains...
Bard® Channel Drain...
Used for placement of cholangiography catheters and other instruments. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: